Stay updated on SPR1NT Clinical Trial
Sign up to get notified when there's something new on the SPR1NT Clinical Trial page.

Latest updates to the SPR1NT Clinical Trial page
- Check6 days agoChange DetectedConsolidated and expanded the Locations section to include multiple US states and international locations (California, Colorado, Florida, Massachusetts, Michigan, Missouri, New York, Ohio, Pennsylvania, Texas, Wisconsin, New South Wales, Ontario) and removed the previous per-location subpages. The page revision updated from v3.3.2 to v3.3.3.SummaryDifference1%

- Check14 days agoNo Change Detected
- Check15 days agoNo Change Detected
- Check23 days agoNo Change Detected
- Check30 days agoChange DetectedThe Publications section text has been updated to indicate that PubMed-sourced publications are automatically filled, replacing the prior wording, and the Revision label updated from v3.2.0 to v3.3.2.SummaryDifference0.1%

- Check37 days agoChange DetectedRemoved the government funding lapse notice banner from the page; no study content or critical details were changed. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.3%

- Check52 days agoChange DetectedScreenshots indicate cosmetic UI changes (layout and styling) with no visible modifications to the study data or eligibility criteria. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

- Check80 days agoChange DetectedCore content updated from a specific disease subtype to a broader category and version bumped to v3.2.0; a government operating-status notice was added.SummaryDifference3%

- Check87 days agoChange Detected- Updated version from v3.0.2 to v3.1.0. - No other content changes detected.SummaryDifference0.1%

Stay in the know with updates to SPR1NT Clinical Trial
Enter your email address, and we'll notify you when there's something new on the SPR1NT Clinical Trial page.